| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |